Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Yoshitsu ADR | TKLF | Mar 28, 2024 | 0.25 | -2.86 |
Yotta Acquisition | YOTA | Mar 28, 2024 | 10.83 | 0.00 |
Yotta Acquisition Unit | YOTAU | Mar 28, 2024 | 11.61 | 0.00 |
Youdao A ADR | DAO | Mar 28, 2024 | 4.02 | +3.08 |
YPF Sociedad Anonima ADR | YPF | Mar 28, 2024 | 19.80 | -1.59 |
YS Biopharma | YS | Mar 28, 2024 | 0.72 | +1.39 |
Yum China | YUMC | Mar 28, 2024 | 39.79 | +2.13 |
Yum! Brands | YUM | Mar 28, 2024 | 138.65 | +0.97 |
Yunhong Green CTI | YHGJ | Mar 28, 2024 | 1.59 | -4.79 |
Yunji ADR | YJ | Mar 28, 2024 | 0.83 | +8.60 |
Zai Lab ADR | ZLAB | Mar 28, 2024 | 16.02 | -1.05 |
Zalatoris II Acquisition | ZLS | Mar 28, 2024 | 10.84 | 0.00 |
Zapp Electric Vehicles Group | ZAPP | Mar 28, 2024 | 0.25 | -1.73 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | Mar 28, 2024 | 44.21 | +1.08 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | Mar 28, 2024 | 58.30 | +1.05 |
Zebra Technologies A | ZBRA | Mar 28, 2024 | 301.44 | +0.76 |
Zedge B | ZDGE | Mar 28, 2024 | 2.77 | +2.21 |
Zentalis Pharmaceuticals | ZNTL | Mar 28, 2024 | 15.76 | +3.75 |
Zentek | ZTEK | Mar 28, 2024 | 1.20 | +1.14 |
Zenvia A | ZENV | Mar 28, 2024 | 2.66 | +12.24 |
Zeo Energy A | ZEO | Mar 28, 2024 | 5.70 | 0.00 |
Zepp Health ADR | ZEPP | Mar 28, 2024 | 1.02 | -0.97 |
ZeroFox | ZFOX | Mar 28, 2024 | 1.12 | -0.89 |
Zeta Global A | ZETA | Mar 28, 2024 | 10.93 | 0.00 |
Zevia A | ZVIA | Mar 28, 2024 | 1.17 | +11.43 |
Zevra Therapeutics | ZVRA | Mar 28, 2024 | 5.80 | -2.36 |
Zhihu A ADR | ZH | Mar 28, 2024 | 0.68 | -2.30 |
Zhongchao A | ZCMD | Mar 28, 2024 | 1.34 | +4.69 |
Ziff Davis | ZD | Mar 28, 2024 | 63.04 | -0.10 |
Zillow Group A | ZG | Mar 28, 2024 | 47.86 | -3.53 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.